BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37923555)

  • 1. KDM4B: A promising oncology therapeutic target.
    Ni F; Tang H; Cheng S; Yu Y; Yuan Z; Chen Y; Zhang E; Wang X
    Cancer Sci; 2024 Jan; 115(1):8-16. PubMed ID: 37923555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KDM4B: A Nail for Every Hammer?
    Wilson C; Krieg AJ
    Genes (Basel); 2019 Feb; 10(2):. PubMed ID: 30759871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells.
    Berry WL; Janknecht R
    Cancer Res; 2013 May; 73(10):2936-42. PubMed ID: 23644528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.
    Chin YW; Han SY
    Expert Opin Ther Pat; 2015 Feb; 25(2):135-44. PubMed ID: 25468267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kdm4b histone demethylase is a DNA damage response protein and confers a survival advantage following γ-irradiation.
    Young LC; McDonald DW; Hendzel MJ
    J Biol Chem; 2013 Jul; 288(29):21376-21388. PubMed ID: 23744078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat shock protein 90 (Hsp90) selectively regulates the stability of KDM4B/JMJD2B histone demethylase.
    Ipenberg I; Guttmann-Raviv N; Khoury HP; Kupershmit I; Ayoub N
    J Biol Chem; 2013 May; 288(21):14681-7. PubMed ID: 23589305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KDM4 Demethylases: Structure, Function, and Inhibitors.
    Jiang Y; Liu L; Yang ZQ
    Adv Exp Med Biol; 2023; 1433():87-111. PubMed ID: 37751137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oncogenic potential of Jumonji D2 (JMJD2/KDM4) histone demethylase overexpression.
    Young LC; Hendzel MJ
    Biochem Cell Biol; 2013 Dec; 91(6):369-77. PubMed ID: 24219278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KDM4B promotes DNA damage response via STAT3 signaling and is a target of CREB in colorectal cancer cells.
    Deng WW; Hu Q; Liu ZR; Chen QH; Wang WX; Zhang HG; Zhang Q; Huang YL; Zhang XK
    Mol Cell Biochem; 2018 Dec; 449(1-2):81-90. PubMed ID: 29633065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KDM4/JMJD2 Histone Demethylase Inhibitors Block Prostate Tumor Growth by Suppressing the Expression of AR and BMYB-Regulated Genes.
    Duan L; Rai G; Roggero C; Zhang QJ; Wei Q; Ma SH; Zhou Y; Santoyo J; Martinez ED; Xiao G; Raj GV; Jadhav A; Simeonov A; Maloney DJ; Rizo J; Hsieh JT; Liu ZP
    Chem Biol; 2015 Sep; 22(9):1185-96. PubMed ID: 26364928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone demethylase KDM4B accelerates the progression of glioblastoma via the epigenetic regulation of MYC stability.
    Wang Z; Cai H; Li Z; Sun W; Zhao E; Cui H
    Clin Epigenetics; 2023 Dec; 15(1):192. PubMed ID: 38093312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KDM4B plays an important role in mitochondrial apoptosis by upregulating HAX1 expression in colorectal cancer.
    Li H; Yang X; Wang G; Li X; Tao D; Hu J; Luo X
    Oncotarget; 2016 Sep; 7(36):57866-57877. PubMed ID: 27506941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reader domain specificity and lysine demethylase-4 family function.
    Su Z; Wang F; Lee JH; Stephens KE; Papazyan R; Voronina E; Krautkramer KA; Raman A; Thorpe JJ; Boersma MD; Kuznetsov VI; Miller MD; Taverna SD; Phillips GN; Denu JM
    Nat Commun; 2016 Nov; 7():13387. PubMed ID: 27841353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KDM4B is a coactivator of c-Jun and involved in gastric carcinogenesis.
    Wu MC; Cheng HH; Yeh TS; Li YC; Chen TJ; Sit WY; Chuu CP; Kung HJ; Chien S; Wang WC
    Cell Death Dis; 2019 Jan; 10(2):68. PubMed ID: 30683841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JmjC Family of Histone Demethylases Form Nuclear Condensates.
    Vicioso-Mantis M; Aguirre S; Martínez-Balbás MA
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone demethylase KDM4B contributes to advanced clear cell renal carcinoma and association with copy number variations and cell cycle progression.
    Tang H; Guan Y; Yuan Z; Guo T; Tan X; Fan Y; Zhang E; Wang X
    Epigenetics; 2023 Dec; 18(1):2192319. PubMed ID: 36952476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances with KDM4 Inhibitors and Potential Applications.
    Wu Q; Young B; Wang Y; Davidoff AM; Rankovic Z; Yang J
    J Med Chem; 2022 Jul; 65(14):9564-9579. PubMed ID: 35838529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1.
    Qiu MT; Fan Q; Zhu Z; Kwan SY; Chen L; Chen JH; Ying ZL; Zhou Y; Gu W; Wang LH; Cheng WW; Zeng J; Wan XP; Mok SC; Wong KK; Bao W
    Oncotarget; 2015 Oct; 6(31):31702-20. PubMed ID: 26397136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone Demethylase KDM4B Promotes DNA Damage by Activating Long Interspersed Nuclear Element-1.
    Xiang Y; Yan K; Zheng Q; Ke H; Cheng J; Xiong W; Shi X; Wei L; Zhao M; Yang F; Wang P; Lu X; Fu L; Lu X; Li F
    Cancer Res; 2019 Jan; 79(1):86-98. PubMed ID: 30459150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover.
    Coffey K; Rogerson L; Ryan-Munden C; Alkharaif D; Stockley J; Heer R; Sahadevan K; O'Neill D; Jones D; Darby S; Staller P; Mantilla A; Gaughan L; Robson CN
    Nucleic Acids Res; 2013 Apr; 41(8):4433-46. PubMed ID: 23435229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.